A Study in Subjects With Retinal Detachment
This study has been completed.
Information provided by:
First received: September 13, 2005
Last updated: November 24, 2008
Last verified: September 2005
The purpose of this trial is to access the tolerability of INS37217 Intravitreal Injection when administered intravitreally in subjects with macula-on or macula-off rhegmatogenous retinal detachment (RRD).
Drug: denufosol tetrasodium (INS37217) Intravitreal Injection
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||A Double-Masked, Randomized, Dose-Ranging Study of a Single Intravitreal (IVT) Injection of INS37217 Intravitreal Injection in Subjects With Retinal Detachment|
Further study details as provided by Merck:
Contacts and Locations